Nasacort (Triamcinolone Acetonide)

Triamcinolone Acetonide, the active ingredient in Nasacort, is a corticosteroid presented as a nasal spray for nasal administration. It is used to treat allergic rhinitis and seasonal nasal congestion by reducing inflammation in the nasal passages.

GNH USA supplies Nasacort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasacort, a nasal corticosteroid, is indicated for conditions involving nasal inflammation and congestion.

Allergic rhinitis: reduces nasal inflammation, itching, and congestion associated with seasonal or perennial allergies. Seasonal nasal congestion: alleviates blockage and pressure caused by seasonal changes. Non‑allergic rhinitis: improves symptoms of chronic nasal congestion not caused by allergens.

Nasacort may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleed) - Headache - Altered taste or bitter taste - Throat irritation - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or ocular pressure increase - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal mucosa

Before initiating Nasacort, consider patient history and potential risks.

Assess patient history: verify prior nasal surgery, trauma, or chronic infections. Avoid concurrent systemic steroids: limit risk of systemic corticosteroid effects. Monitor for infection: discontinue if secondary bacterial or fungal infection develops. Pregnancy and lactation: use only if benefits outweigh potential risks. Store at room temperature: keep in original container, protect from moisture and direct heat.

Nasacort can interact with other medications that affect corticosteroid metabolism or nasal mucosa integrity.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic side effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Live nasal vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedation when combined with sedating antihistamines. - Decongestant nasal sprays: increased risk of nasal irritation. - Antifungal nasal preparations: possible additive mucosal irritation.